Skip to main content
. Author manuscript; available in PMC: 2016 Jun 20.
Published in final edited form as: Int J Pharm. 2015 Apr 15;487(0):167–176. doi: 10.1016/j.ijpharm.2015.04.030

Table 3.

Composition of ODT formulations

ODT Formulations (% w/w) F1 F2 F3 F4 F5 F6 F7 F8
CC2 Extrudates 50 50 -- -- -- -- -- --
CC9 Extrudates -- -- 50 50 -- -- -- --
CC10 Extrudates -- -- -- -- 50 50 -- --
CC11 Extrudates -- -- -- -- -- -- 50 50
Mannitol 44.5 44.5 44.5 44.5 44.5 44.5 44.5 44.5
Polyplasdone XL 5 -- 5 -- 5 -- 5 --
Polyplasdone XL-10 -- 5 -- 5 -- 5 -- 5
Magnesium Stearate 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5